Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4594959 | 0.91 | SMN1; SMN2 (0.43) | SMN1; SMN2MAPTHPGDMGLLHSD17B10 | |
| SCHEMBL343269 | 0.81 | SMN1; SMN2 (0.45) | SMN1; SMN2MAPTHPGDMGLLHSD17B10 | |
| SCHEMBL1453001 | 0.81 | SMN1; SMN2 (0.45) | SMN1; SMN2MAPTHPGDMGLLHSD17B10 | |
| SCHEMBL5173197 | 0.81 | SMN1; SMN2 (0.45) | SMN1; SMN2MAPTHPGDMGLLHSD17B10 | |
| Fluoride SCHEMBL1336886 | 0.79 | MAOA (0.48) | SMN1; SMN2MAPTHPGDMGLLHSD17B10 | |
| SCHEMBL24012949 | 0.77 | MAOA (0.41) | SMN1; SMN2MAPTHPGDMGLLHSD17B10 | |
| SCHEMBL3885342 | 0.77 | MAOA (0.41) | SMN1; SMN2MAPTHPGDMGLLHSD17B10 | |
| SCHEMBL9427770 | 0.77 | MAOA (0.41) | SMN1; SMN2MAPTHPGDMGLLHSD17B10 | |
| SCHEMBL7362590 | 0.77 | MAOA (0.52) | SMN1; SMN2MAPTHPGDMGLLHSD17B10 | |
| SCHEMBL23331965 | 0.77 | MAOA (0.52) | SMN1; SMN2MAPTHPGDMGLLHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109609973-B | Preparation method and application of organic sulfide modified carbon nanotube loaded low-content palladium composite material | 温州大学 | 2020-12-22 | — | — | CN | claimed |
| US-8987430-B2 | Efficient and scalable process for the manufacture of fondaparinux sodium | RELIABLE BIOPHARMACEUTICAL CORPORATION (US) | 2015-03-24 | — | — | US | claimed |
| US-11500247-B2 | Liquid crystal sensor | PLATYPUS TECHNOLOGIES, LLC (US) | 2022-11-15 | — | — | US | disclosed |
| CN-113993719-A | Trisulfide compound | 住友化学株式会社 | 2022-01-28 | — | — | CN | disclosed |
| US-20200409221-A1 | LIQUID CRYSTAL SENSOR | PLATYPUS TECHNOLOGIES, LLC | 2020-12-31 | — | — | US | disclosed |
| CN-109609973-B | Preparation method and application of organic sulfide modified carbon nanotube loaded low-content palladium composite material | 温州大学 | 2020-12-22 | — | — | CN | disclosed |
| US-20170212088-A1 | DETECTION OF GAS-PHASE ANALYTES USING LIQUID CRYSTALS | PLATYPUS TECHNOLOGIES, LLC | 2017-07-27 | — | — | US | disclosed |
| EP-2809678-B1 | AN EFFICIENT AND SCALABLE PROCESS FOR THE MANUFACTURE OF FONDAPARINUX SODIUM | RELIABLE BIOPHARMACEUTICAL CORP (US) | 2017-03-22 | — | — | EP | disclosed |
| US-9575037-B2 | Detection of gas-phase analytes using liquid crystals | PLATYPUS TECHNOLOGIES, LLC (US) | 2017-02-21 | — | — | US | disclosed |
| US-20160274084-A1 | DETECTION OF VAPOR PHASE COMPOUNDS BY CHANGES IN PHYSICAL PROPERTIES OF A LIQUID CRYSTAL | PLATYPUS TECHNOLOGIES, LLC | 2016-09-22 | — | — | US | disclosed |
| US-9417245-B2 | Porphyrinic compounds for use in flow cytometry | NORTH CAROLINA STATE UNIVERSITY (US) | 2016-08-16 | — | — | US | disclosed |
| WO-2004000887-A1 | COMPOUNDS THAT BIND TO THE INTERFERON-GAMMA, PREPARATION METHOD THEREOF AND MEDICAMENTS CONTAINING SAME | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2003-12-31 | — | — | WO | disclosed |
| EP-0700291-B1 | 15-SUBSTITUTED 4-AZASTEROIDS | MERCK & CO INC (US) | 1998-09-16 | — | — | EP | disclosed |
| EP-0700291-A4 | 15-SUBSTITUTED 4-AZASTEROIDS | MERCK & CO INC (US) | 1996-07-03 | — | — | EP | disclosed |
| EP-0700291-A1 | 15-SUBSTITUTED 4-AZASTEROIDS | MERCK & CO. INC. (US) | 1996-03-13 | — | — | EP | disclosed |
| US-5359071-A | Selective antagonist of testosterone 5-alpha-reductase 1 | MERCK & CO., INC. (US) | 1994-10-25 | — | — | US | disclosed |
| WO-1994020104-A1 | 15-SUBSTITUTED 4-AZASTEROIDS | MERCK & CO, INC. (US) | 1994-09-15 | — | — | WO | disclosed |
| US-4656233-A | \"Living\" polymers and chain transfer-regulated polymerization process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-04-07 | — | — | US | disclosed |
| EP-0186330-A1 | \"Living\" polymers and chain transfer-regulated polymerization process | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-07-02 | — | — | EP | disclosed |
| EP-0021883-A2 | N-acyl-amino acid derivatives and pharmaceutical compositions containing them, intermediates and starting compounds | MERRELL TORAUDE ET COMPAGNIE (FR) | 1981-01-07 | — | — | EP | disclosed |